High-dose Cholecalciferol Reduces Multiple Sclerosis Disease Activity after a Clinically Isolated Syndrome : Results of a 24-Month Placebo-Controlled Randomized Trial (D-Lay MS)
Eric Thouvenot,David Laplaud,Christine Lebrun-Frenay,Nathalie Derache,Emmanuelle Le Page,Elisabeth Maillart, Caroline Froment,Giovanni Castelnovo,Olivier Casez,Marc Coustans,Anne-Marie Guennoc,Olivier Heinzlef,Laurent Magy,Chantal Nifle,Xavier Ayrignac,Agnes Fromont,Nathalie Caucheteux,Nicolas Gaillard,Ivania Patry,Jerome De Seze,Romain Deschamps,Pierre Clavelou,Damien Biotti,Gilles Edan,William Camu,Hanane Agherbi,Christophe Demattei, Fabbro-Peray Pascale,Thibault Mura,Manon Rival MULTIPLE SCLEROSIS JOURNAL（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper